Websites, domains, hosts that links to azprivacynotice.com

IRESSA® (gefitinib) is a treatment for patients.

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Is your severe asthma e-asthma? Read about e-asthma (eosinophilic asthma) and find out more about severe asthma and eosinophils.

Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.

FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.

Get your free e-book for breathing tips, exercises, and more, plus receive bonus content personalized to your needs from our added feature BREATHABLE.

Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.

Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

FASENRA™ (benralizumab) is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in adults whose asthma is not controlled with their current asthma medicines.

BreathABLE from SYMBICORT (budesonide/formoterol fumarate dihydrate) was created to help you control and manage difficulty breathing if you have COPD.

Official health care professional website for PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg), a maintenance asthma treatment for patients 6 years of age and older.

Get helpful information about BRCA mutations and testing to see how BRCA genetics can affect your cancer risk.

Eosinophilic asthma can have a serious long-term impact on asthma severity and control in your patients. Sign up for updates on eosinophilic asthma from AstraZeneca.

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

LYNPARZA® (olaparib) is the first and only PARP inhibitor approved in 2 distinct settings: maintenance for recurrent ovarian cancer and following 3 or more lines of prior chemotherapy.

Learn more about the now-approved FASENRA for add-on treatment of eosinophilic asthma.

Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to help reduce A1C levels.

Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.

BYETTA is a non-insulin type 2 diabetes injection medication for adults.

Information about CRESTOR® (rosuvastatin calcium), a prescription cholesterol medicine that helps lower LDL cholesterol when diet and exercise alone are not enough.

Learn about once-weekly BYDUREON, the BYDUREON Pen, and how BYDUREON affected A1C levels and more in multiple clinical trials.

Learn what makes opioid-induced constipation different and how to talk to your health care provider about OIC and prescription treatment options.

BEVESPI AEROSPHERE is a twice-daily long term treatment for adults with COPD.

Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

Parent and caregiver information for SYNAGIS, a therapy to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children at high risk for severe lung disease from RSV.

FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.

Help protect against seasonal flu with FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) - the flu vaccine that starts working in the nose.

Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).

Official patient Web site for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects

Access 360 provides resources and information to help patients and health care providers gain access to AstraZeneca medicines.

Official patient site. Learn about PULMICORT FLEXHALER a medication for the maintenance treatment of asthma symptoms in adults and children 6 years or older. Find information about the inhaler and side effects and a How to Use FLEXHALER video.

Patient information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.

Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.

Fit2Me™ a FREE food and activity program that's custom fit to you and your health challenges. Plus, there's personalized treatment information and support!

Find out more about QTERN® (dapagliflozin and saxagliptin) and how it may help your patients in managing type 2 diabetes.

Find out more about PD-L1 inhibition, CTLA-4 inhibition, other Immuno-Oncology pathways like OX40 agonism, Anti-CEA BiTE, STAT3 inhibition, and PD-1 inhibition.

Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.

Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.

BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long‐term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

IMFINZI™ (durvalumab) is an immunotherapy used to treat a type of cancer in the bladder and urinary tract called urothelial carcinoma. Learn more about IMFINZI.

LYNPARZA®(olaparib) is a type of targeted therapy for ovarian cancer called a PARP inhibitor. LYNPARZA may be used at different stages of ovarian cancer treatment.

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Think you know about RSV Disease? Learn more about Respiratory Syncytial Virus, risk factors, and protection tips for your baby & infant.